1. Шостак Н.А. Современные аспекты диагностики и лечения дегенеративных заболеваний позвоночника и суставов. Фарматека. 2005; 20: 80–5.
2. Altman RD et al. on behalf of the American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis on the hip and the knee. Arthritis Rheum 2000; 43: 1905–15.
3. Rostom A, Muir R, Dube C et al. Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf 2009; 1: 47–71.
4. Kriegel W, Korff K, Ehrlich J et al. Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis. Int J Clin Pract 2001; 55 (8): 510–4.
5. Mukherjee P, Rachita C, Aisen PS et al. Non-steroidal antiinflammatory drugs protect against chondrocyte apoptotic death. Clin Exp Rheumatol 2001; 19 (1 Suppl. 22): S7–11.
Авторы
О.В.Котова
ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России